Cargando…
Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?
For over 40 years the standard treatment for acute myeloid leukemia (AML) patients has been a combination of chemotherapy consisting of cytarabine and an anthracycline such as daunorubicin. This standard treatment results in complete remission (CR) in the majority of AML patients. However, despite t...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532610/ https://www.ncbi.nlm.nih.gov/pubmed/28665351 http://dx.doi.org/10.3390/cancers9070074 |